164669-07-2
164669-07-2
Chemical Structure
Cdk5 Substrate
- CAS No.: 164669-07-2
- Formula:C53H99N15O12
- Molecular Weight:1138.45
InChIKey: ZSZMVAFYNVHXHA-BJSZDZKQSA-N
SMILES: O=C(N(CCC1)[C@@H]1C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)=O)=O)=O)[C@H]([C@H](O)C)NC([C@H](CCCCN)NC([C@@H]2CCCN2)=O)=O
Biological Activity: Cdk5 Substrate is a biological active peptide. (substrate for the cdc2 protein kinase)
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cdk5 Substrate | 98.80% | Cdk5 Substrate is a biological active peptide. (substrate for the cdc2 protein kinase) | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Syntide 2 | Syntide 2, a Ca2+- and calmodulin (CaM)-dependent protein kinase II (CaMKII) substrate peptide, selectively inhibits the gibberellin (GA) response, leaving constitutive and abscisic acid-regulated events unaffected. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
G-Subtide | G-Subtide is a G-substrate peptide localized in Purkinje cells of the cerebellum. G-Subtide has little activity distinct from background and is a preferentially phosphorylated peptide substrate of recombinant PfPKG2 protein. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DRGN-1 | DRGN-1 is an antimicrobial peptide. DRGN-1 exhibits potent antimicrobial and anti-biofilm activities, inhibiting both Gram-negative and Gram-positive bacteria, with an EC50 range of 0.50-4.62 μM. DRGN-1 exerts its antimicrobial effect by disrupting bacterial membrane permeability and slightly depolarizing the membrane potential. DRGN-1 inhibits the formation of biofilms of single bacterial species and mixed species of Pseudomonas aeruginosa and Staphylococcus aureus. DRGN-1 can significantly promote the healing of uninfected and mixed biofilm-infected mouse wounds. DRGN-1 can be used for the study of infections. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hydrostatin-TL1 | 98.45% | Hydrostatin-TL1 (H-TL1), a nine-amino-acid peptide, is a TNF-α antagonist. Hydrostatin-TL1 can be isolated from the venom gland of sea snake Hydrophis cyanocinctus. H-TL1 competitively inhibits the interaction between TNF-α/TNFR1 and attenuates the cytotoxicity and inflammation of TNF-α. Hydrostatin-TL1 can be used for TNF-α-associated inflammatory diseases, such as rheumatoid arthritis, osteoporosis and inflammatory bowel disease (IBD) research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nucleoplasmin | ||||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Histone H1-derived Peptide | 99.92% | Histone H1-derived Peptide is a phosphopeptide and the peptide substrates containes a sequence in accordance with the optimal recognition motif for CDK, can be used to detecting CDK1-cyclinB1 enzyme activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
KRAKAKTTKKR | KRAKAKTTKKR is a protein kinase C substrate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
[Ala9,10, Lys11,12] Glycogen Synthase (1-12) | [Ala9,10, Lys11,12] Glycogen Synthase (1-12) is a selective substrate for phosphorylation by protein kinase C (PKC). [Ala9,10, Lys11,12] Glycogen Synthase (1-12) can be used to determine the activity of protein kinase C. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ac-KLKKTETQ-NH2 | Ac-KLKKTETQ-NH2, a peptide, has the potential for cosmetics research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
PKCε inhibitor peptide,myristoylated | PKCε inhibitor peptide,myristoylated (Myr-PKCε-) is a cell permeable myristic acid conjugated PKC peptide inhibitor that attenuates NO release in cultured human umbilical vein endothelial cells (HUVECs). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
